W vingerhoed

[UTSW Radiation Oncology @UTSW_RadOnc]

🗓️Save the date for the PULSAR® 2nd Consortium Meeting at #ASTRO25!

Led by Dr. @BobTimmermanMD, our department pioneered this personalized radiotherapy technique, potentially offering advantages over strategies such as conventionally fractionated radiation therapy.

[ESTRO @ESTRO_RT]

Practical Recommendations for the Management of Radiodermatitis, on behalf of the ESTRO RTT committee, published in Radiation Oncology.
👉 Read it before your patients: https://t.co/I44ERhWfVc
@BioMedCentral

[ESTRO @ESTRO_RT]

✨ ESTRO Board Elections 2025: Meet Piet Ost, candidate for the Clinical seat at ESTRO. 🗳
👉 Get to know his vision and goals in this short interview: https://t.co/XqRUDpRF64
#ESTROElections

[Piet Ost @piet_ost]

Here we go again! @ESTRO_RT SBRT course, more than a decade ongoing and still very popular thanks to @Mat_Guc and Dirk Verellen who keep refreshing the format!

[Dr. Nina Niu Sanford @NiuSanford]

First clinical PULSAR study is out!

Congrats @MDohopolski, @TuDDan, @BobTimmermanMD & rest of UTSW CNS team!

https://t.co/DJ9yJemn5K

[W vingerhoed @VingerhoedW]

https://t.co/Aek4qAMDDM

[C. Jillian Tsai, MD, PhD @CJTsaiMDPhD]

☢️Missed this session?

Check out our posters on SIM-FREE SINGLE-FX SBRT!

@ASTRO_org #ASTRO24 @JoannaJavor @RadMedPM @pmcancercentre @DKirschMDPhD @ldawsonmd @naummalik @UofTDRO @KV_Dharmarajan @aislingbarryro @PercyLeeMD @naummalik @MichaelYanMD @MFGensheimer @YatTsang @MskMedPhys

[Piet Ost @piet_ost]

Immensely grateful for having received the #ESTRO24 award on behalf of the STORM team honoring the legacy of Prof. Donal Hollywood. Please find the main findings below. Supported by @komop_tgkanker and @Movember

[Jeff Ryckman @jryckman3]

Peter Hoskin: what do we know about dose constraints for clinical use?

According to Dr. Hoskin himself, this presentation might as well have been a blank slide. Conclusion: There's still much we don't know, and plenty to learn! #ReCARE #ReCOG #ESTRO24

[James Good @drjamesgood]

Spicy perspectives on oligometastatic disease from @piet_ost at #ESTRO2024

[JFC @jfcdrr]

@DavidSherMD Currently, we use CBCT image for online adaptive prostate SBRT, with a TrueBeam:
https://t.co/0RXSpl1GNL

@marslain @coral_laosa @sandra_moragues @med_dosimetry

[Filippo Alongi @alongi_filippo]

Great provocative editorial!
“it became appar-
ent that the #radiationoncology community was approach-
ing #SABR constraints through the lens of conventionally
fractionated RT, an approach we believe has
diminished the potential efficacy/effect of #SABR.

https://t.co/Sg0SiOtbxJ

[Robert Timmerman @BobTimmermanMD]

This editorial will raise some ire, but we mean no disrespect. Considerable thought went into a radiotherapy equivalent of a strategy that has enabled surgical success for centuries. We should have been exploring this for at least decades.

[Renée Bultijnck @ReneeBultijnck]

🔎 Zorgverleners binnen #oncologie in Vlaanderen?

➡️ Bepaal mee de prioriteiten binnen psychosociaal onderzoek. 👊

Hoe? Simpel, vul onze survey in https://t.co/lpcAjLVi71

@uzgent @crighent @ugent_fge @ugent @komop_tgkanker @Stkstichting @ElkeRammant @Jdmunter1

[Tipsro Tweets @TipsroTweets]

With our journal expanding we thank all those who have recently agreed to come on board as reviewers. Thank you #RTT and #Radonc community 🙏@ESTRO_RT

[Piet Ost @piet_ost]

Join me and @Mat_Guc for the latest on SBRT for oligometastatic cancer. With great speakers like @drdavidpalma @_ShankarSiva @GiulioFrancoli1 and more!

[Piet Ost @piet_ost]

Thanks to @komop_tgkanker and all the people supporting it, @gzaziekenhuizen and the Iridium Network will be able to conduct 2 new trials: PRADA (@mchiels) and OligoRare (me and @Mat_Guc with @EORTC), trying to improve outcomes for cancer patients!

[Melanie Machiels @mchiels]

Elective node irradiation including IMN for all high-risk #breastcancer patients from now on!

[Abdu BOUAGGAD @bouaggad_abdu]

@tobiasgilk catastrophic incident. it could harm patient and damage the MRI

Mittendorff L, Young A, Sim J. A narrative review of current and emerging MRI safety issues: What every MRI technologist (radiographer) needs to know. J Med Radiat Sci. 2022 Jun;69(2):250-260. doi: 10.1002/jmrs.546

[W vingerhoed @VingerhoedW]

https://t.co/s5X2roixnN

After 100 years of standard fractionation lets us walk new paths. Read 👇